Gene · 10397
Papers3,293
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,121 to 1,140 of 3,293
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identifying Molecular Signatures of Distinct Modes of Collective Migration in Response to the Microenvironment Using Three-Dimensional Breast Cancer Models. | Cancers (Basel) | 2021 | 33804802 | PubTator, text mining | PubMed |
| Prominent Role of Histone Modifications in the Regulation of Tumor Metastasis. | Int J Mol Sci | 2021 | 33803458 | PubTator, text mining | PubMed |
| Mucosa-Associated Lymphoid Tissue 1 Is an Oncogene Inducing Cell Proliferation, Invasion, and Tumor Growth via the Upregulation of NF-κB Activity in Human Prostate Carcinoma Cells. | Biomedicines | 2021 | 33802402 | PubTator, text mining | PubMed |
| Hypoxia-Induced Reactivity of Tumor-Associated Astrocytes Affects Glioma Cell Properties. | Cells | 2021 | 33802060 | PubTator, text mining | PubMed |
| Novel Combinatorial Approaches to Tackle the Immunosuppressive Microenvironment of Prostate Cancer. | Cancers (Basel) | 2021 | 33800156 | PubTator, text mining | PubMed |
| Androgen receptor signalling confers clonogenic and migratory advantages in urothelial cell carcinoma of the bladder. | Mol Oncol | 2021 | 33797847 | PubTator, text mining | PubMed |
| Machine Learning for Building Immune Genetic Model in Hepatocellular Carcinoma Patients. | J Oncol | 2021 | 33790969 | PubTator, text mining | PubMed |
| Landscapes of cellular phenotypic diversity in breast cancer xenografts and their impact on drug response. | Nat Commun | 2021 | 33790302 | PubTator, text mining | PubMed |
| Decoding the heterogeneous landscape in the development prostate cancer. | Oncol Lett | 2021 | 33777200 | PubTator, text mining | PubMed |
| NEDD4 Induces K48-Linked Degradative Ubiquitination of Hepatitis B Virus X Protein and Inhibits HBV-Associated HCC Progression. | Front Oncol | 2021 | 33767993 | PubTator, text mining | PubMed |
| 3D-FV-FE Aeroacoustic Larynx Model for Investigation of Functional Based Voice Disorders. | Front Physiol | 2021 | 33762964 | PubTator, text mining | PubMed |
| The Role of Neoadjuvant Chemotherapy in Locally Advanced Colon Cancer. | Cancer Manag Res | 2021 | 33762848 | PubTator, text mining | PubMed |
| Distinct DNA methylation patterns associated with treatment resistance in metastatic castration resistant prostate cancer. | Sci Rep | 2021 | 33758253 | PubTator, text mining | PubMed |
| Integrated Redox Proteomic Analysis Highlights New Mechanisms of Sensitivity to Silver Nanoparticles. | Mol Cell Proteomics | 2021 | 33757833 | PubTator, text mining | PubMed |
| Intratumor heterogeneity of breast cancer detected by epialleles shows association with hypoxic microenvironment. | Theranostics | 2021 | 33754068 | PubTator, text mining | PubMed |
| Distinct placental molecular processes associated with early-onset and late-onset preeclampsia. | Theranostics | 2021 | 33754042 | PubTator, text mining | PubMed |
| Identification of hub genes-based predictive model in hepatocellular carcinoma by robust rank aggregation and regression analysis. | J Cancer | 2021 | 33753986 | PubTator, text mining | PubMed |
| Respiratory delivery of favipiravir-tocilizumab combination through mucoadhesive protein-lipidic nanovesicles: prospective therapeutics against COVID-19. | Virusdisease | 2021 | 33748347 | PubTator, text mining | PubMed |
| A Risk Signature with Nine Stemness Index-Associated Genes for Predicting Survival of Patients with Uterine Corpus Endometrial Carcinoma. | J Oncol | 2021 | 33747079 | PubTator, text mining | PubMed |
| Clonal architecture in mesothelioma is prognostic and shapes the tumour microenvironment. | Nat Commun | 2021 | 33741915 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10397/papers?page=57